评价Tb标记的二酸盐作为潜在的骨向剂
Pavle Sitarica1, Aleksandar Vukadinović1, Miloš Marić1
1"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.
International journal of molecular sciences
|November 13, 2025
概括
针对骨的新型放射性药物 - - 标记为特比-161的酸 (HEDP) 和酸 (ZOL) - - 显示出高的骨吸收和稳定性. 这些有前途的药物为治疗骨转移提供了更好的安全性和选择性.
科学领域:
- 核医学和放射性药物化学.
- 开发针对骨疾病的向治疗方法.
背景情况:
- 骨转移和骨疾病需要有效的骨向剂.
- 二酸盐以其寻找骨的特性而闻名.
- -161 (161Tb) 是用于向放射性核酸治疗的有前途的放射性核酸.
研究的目的:
- 给放射性标记的乙酸 (HEDP) 和酸 (ZOL) 带有161Tb.
- 评估161Tb-HEDP和161Tb-ZOL作为向骨放射性药物的体外和体内性能.
- 评估其用于骨转移放射性核素治疗的潜力.
主要方法:
- 在pH 7.0下对HEDP和ZOL用161Tb进行放射性标记.
- 在盐水和人血清中进行体外稳定性研究.
- 氧酸结合亲和力和血蛋白结合测试.
- 在Wistar大鼠的体内生物分布研究.
- 电化学分析和密度函数理论 (DFT) 计算.
主要成果:
- 这两种复合物都实现了高放射性标记产量 (>98%) 和卓越的体外稳定性.
- 161Tb-HEDP和161ZOL表现出强烈的酸结合,快速的血液清理和最小的软组织积累.
- 与Tb-HEDP相比,Tb-ZOL的脏和肝脏积累较低,表明安全性和选择性更高.
- 这两种复杂物表现出优越的骨向性,而非化TbCl的161.
- DFT的计算证实了连接物协调和结构稳定.
结论:
- 标有Tb标签的HEDP和ZOL是稳定的,向骨的放射性药物,具有有利的生物分布特征.
- 这些药物显示出针对骨转移和其他骨疾病的向放射性核素治疗的潜力.
- 需要进一步的研究来探索它们的治疗效果.
关键词:
标有161Tb的二酸盐.在 DFT 方面,它是最重要的.这就是HEDP.在 ZOLOL 中,你会看到 ZOL.生物分销生物分销准骨的目标是骨.电化学行为 电化学行为基亚帕提特结合基亚帕提特结合更多相关视频
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
18.4K
07:00Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
17.3K
相关概念视频
Drug Distribution: Tissue Binding
3.8K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.8K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
